rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    ORMP
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Oramed COO & CBO Joshua Hexter sells $135,330 in shares
      Oct 2Investing.comORMP
      Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock
      Oct 2Investing.comORMP
      Type 2 Diabetes Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Ionis Pharma, Eli Lilly, Oramed Pharma, AstraZeneca, Novo Nordisk, Jiangsu
      Sep 25BarchartORMP
      Oramed Pharm Shareholders Back Governance and Incentive Plan

      Tipranks Press Release.

      Sep 18The Globe and MailORMP
      Oramed Pharmaceuticals shareholders approve board, stock plan amendment at annual meeting
      Sep 17Investing.comORMP
      Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP)
      Sep 11Seeking AlphaDRTSLFWDORMPSCLX

      This is the newest page. Registered accounts read further back.